title: Tumor necrosis factor alpha (TNF-alpha) activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B cells.
abstract: The biological actions of tumor necrosis factor alpha (TNF-alpha) are mediated by two cell surface receptors, TNFR-1 and TNFR-2. These receptors do not display protein tyrosine kinase activity. Nevertheless, an early TNF-induced activation of specific tyrosine kinases has been reported as an important cue to the cellular response to this cytokine. Here we present evidence that TNF-alpha induces the activation of the cytoplasmic Janus tyrosine kinases Jak1 and Tyk2 in both human healthy peripheral and lymphoma B cells. This event was accompanied by the recruitment of a specific set of latent cytosolic transcription factors, Stat3 and Stat5b. Furthermore, Jak1 coprecipitated with TNFR-1 after TNF-alpha treatment. These data suggest that at least in human B cells this cytokine can exert its biological effects through the Jak-Stat signaling pathway and that such signals are initiated through an interaction between TNFR-1 and Jak 1.
authors.affiliation: Cell Signaling Unit, Department of Biomorphology, School of Medicine, University of Chieti, 66100 Chieti, Italy. s.miscia@morpho.unich.it
authors.forename: Sebastiano
authors.initials: S
authors.lastname: Miscia
authors.forename: Marco
authors.initials: M
authors.lastname: Marchisio
authors.forename: Alfredo
authors.initials: A
authors.lastname: Grilli
authors.forename: Valentina
authors.initials: V
authors.lastname: Di Valerio
authors.forename: Lucia
authors.initials: L
authors.lastname: Centurione
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Sabatino
authors.forename: Francesco
authors.initials: F
authors.lastname: Garaci
authors.forename: Giorgio
authors.initials: G
authors.lastname: Zauli
authors.forename: Ezio
authors.initials: E
authors.lastname: Bonvini
authors.forename: Angela
authors.initials: A
authors.lastname: Di Baldassarre
mesh_terms: D015703:Antigens, CD / Q000378:metabolism*; D017209:Apoptosis / Q000187:drug effects; D001402:B-Lymphocytes / Q000187:drug effects / Q000201:enzymology* / Q000648:ultrastructure; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004268:DNA-Binding Proteins / Q000378:metabolism*; D004789:Enzyme Activation; D006801:Humans; D053613:Janus Kinase 1; D016393:Lymphoma, B-Cell / Q000201:enzymology*; D008856:Microscopy, Fluorescence; D008894:Milk Proteins; D010766:Phosphorylation; D011505:Protein-Tyrosine Kinases / Q000378:metabolism*; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism*; D047888:Receptors, Tumor Necrosis Factor, Type I; D050796:STAT3 Transcription Factor; D050799:STAT5 Transcription Factor; D015398:Signal Transduction; D015534:Trans-Activators / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
chemical_list: D015703:Antigens, CD; D004268:DNA-Binding Proteins; D008894:Milk Proteins; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; D050799:STAT5 Transcription Factor; C494095:STAT5B protein, human; D015534:Trans-Activators; D014409:Tumor Necrosis Factor-alpha; D011505:Protein-Tyrosine Kinases; C507904:JAK1 protein, human; D053613:Janus Kinase 1